HEADER SERINE PROTEASE INHIBITOR 01-MAR-96 3SSI TITLE PROTEINASE INHIBITOR SSI (STREPTOMYCES SUBTILISIN, INHIBITOR) FROM TITLE 2 STREPTOMYCES ALBOGRISEOLUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: STREPTOMYCES SUBTILISIN INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SSI SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES ALBOGRISEOLUS; SOURCE 3 ORGANISM_TAXID: 1887; SOURCE 4 STRAIN: S-3253 KEYWDS SSI, SERINE PROTEASE INHIBITOR, SUBTILISIN BPN EXPDTA X-RAY DIFFRACTION AUTHOR T.SUZUKI,T.NONAKA,Y.MITSUI REVDAT 3 05-JUN-24 3SSI 1 REMARK REVDAT 2 24-FEB-09 3SSI 1 VERSN REVDAT 1 17-AUG-96 3SSI 0 SPRSDE 17-AUG-96 3SSI 2SSI JRNL AUTH T.SUZUKI JRNL TITL STRUCTURAL MODULATION OF THE PROTEIN PROTEINASE INHIBITOR JRNL TITL 2 SSI (STREPTOMYCES SUBTILISIN INHIBITOR) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.TAKEUCHI,T.NONAKA,K.T.NAKAMURA,S.KOJIMA,K.MIURA,Y.MITSUI REMARK 1 TITL CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR REMARK 1 TITL 2 COMPLEXED WITH BOVINE TRYPSIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 89 4407 1992 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.TAKEUCHI,Y.SATOW,K.T.NAKAMURA,Y.MITSUI REMARK 1 TITL REFINED CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' REMARK 1 TITL 2 AND STREPTOMYCES SUBTILISIN INHIBITOR AT 1.8 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 221 309 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.TAKEUCHI,S.NOGUCHI,Y.SATOW,S.KOJIMA,I.KUMAGAI,K.MIURA, REMARK 1 AUTH 2 K.T.NAKAMURA,Y.MITSUI REMARK 1 TITL MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': REMARK 1 TITL 2 CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED REMARK 1 TITL 3 PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN REMARK 1 TITL 4 INHIBITOR) REMARK 1 REF PROTEIN ENG. V. 4 501 1991 REMARK 1 REFN ISSN 0269-2139 REMARK 1 REFERENCE 4 REMARK 1 AUTH U.CHRISTENSEN,S.ISHIDA,S.ISHII,Y.MITSUI,Y.IITAKA,J.MCCLARIN, REMARK 1 AUTH 2 R.LANGRIDGE REMARK 1 TITL INTERACTIONS OF STREPTOMYCES SUBTILISIN INHIBITOR WITH REMARK 1 TITL 2 STREPTOMYCES GRISEUS PROTEASES A AND B. ENZYME KINETIC AND REMARK 1 TITL 3 COMPUTER SIMULATION STUDIES REMARK 1 REF J.BIOCHEM.(TOKYO) V. 98 1263 1985 REMARK 1 REFN ISSN 0021-924X REMARK 1 REFERENCE 5 REMARK 1 EDIT K.HIROMI, K.AKASAKA, Y.MITSUI, B.TONOMURA, S.MURAO REMARK 1 REF PROTEIN PROTEASE INHIBITOR: 1985 REMARK 1 REF 2 THE CASE OF STREPTOMYCES REMARK 1 REF 3 SUBTILISIN INHIBITOR (SSI) REMARK 1 PUBL AMSTERDAM : ELSEVIER SCIENCE PUBLISHERS REMARK 1 REFN REMARK 1 REFERENCE 6 REMARK 1 AUTH S.HIRONO,H.AKAGAWA,Y.MITSUI,Y.IITAKA REMARK 1 TITL CRYSTAL STRUCTURE AT 2.6 A RESOLUTION OF THE COMPLEX OF REMARK 1 TITL 2 SUBTILISIN BPN' WITH STREPTOMYCES SUBTILISIN INHIBITOR REMARK 1 REF J.MOL.BIOL. V. 178 389 1984 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 7 REMARK 1 AUTH Y.SATOW,Y.WATANABE,Y.MITSUI REMARK 1 TITL SOLVENT ACCESSIBILITY AND MICROENVIRONMENT IN A BACTERIAL REMARK 1 TITL 2 PROTEIN PROTEINASE INHIBITOR SSI (STREPTOMYCES SUBTILISIN REMARK 1 TITL 3 INHIBITOR) REMARK 1 REF J.BIOCHEM.(TOKYO) V. 88 1739 1980 REMARK 1 REFN ISSN 0021-924X REMARK 1 REFERENCE 8 REMARK 1 AUTH S.HIRONO,K.T.NAKAMURA,Y.IITAKA,Y.MITSUI REMARK 1 TITL CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH ITS REMARK 1 TITL 2 PROTEIN INHIBITOR STREPTOMYCES SUBTILISIN INHIBITOR. THE REMARK 1 TITL 3 STRUCTURE AT 4.3 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 131 855 1979 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 9 REMARK 1 AUTH Y.MITSUI,Y.SATOW,Y.WATANABE,Y.IITAKA REMARK 1 TITL CRYSTAL STRUCTURE OF A BACTERIAL PROTEIN PROTEINASE REMARK 1 TITL 2 INHIBITOR (STREPTOMYCES SUBTILISIN INHIBITOR) AT 2.6 A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 131 697 1979 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 10 REMARK 1 AUTH Y.MITSUI,Y.SATOW,Y.WATANABE,S.HIRONO,Y.IITAKA REMARK 1 TITL CRYSTAL STRUCTURES OF STREPTOMYCES SUBTILISIN INHIBITOR AND REMARK 1 TITL 2 ITS COMPLEX WITH SUBTILISIN BPN REMARK 1 REF NATURE V. 277 447 1979 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 11 REMARK 1 AUTH Y.SATOW,Y.MITSUI,Y.IITAKA REMARK 1 TITL CRYSTAL STRUCTURE OF A PROTEIN PROTEINASE INHIBITOR, SSI REMARK 1 TITL 2 (STREPTOMYCES SUBTILISIN INHIBITOR), AT 4 A RESOLUTION REMARK 1 REF J.BIOCHEM.(TOKYO) V. 84 897 1978 REMARK 1 REFN ISSN 0021-924X REMARK 1 REFERENCE 12 REMARK 1 AUTH Y.MITSUI,Y.SATOW,T.SAKAMAKI,Y.IITAKA REMARK 1 TITL CRYSTAL STRUCTURE OF A PROTEIN PROTEINASE INHIBITOR, REMARK 1 TITL 2 STREPTOMYCES SUBTILISIN INHIBITOR, AT 2.3 ANGSTROM REMARK 1 TITL 3 RESOLUTION REMARK 1 REF J.BIOCHEM.(TOKYO) V. 82 295 1977 REMARK 1 REFN ISSN 0021-924X REMARK 1 REFERENCE 13 REMARK 1 AUTH Y.SATOW,Y.MITSUI,Y.IITAKA,S.MURAO,S.SATO REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY INVESTIGATION OF A NEW REMARK 1 TITL 2 ALKALINE PROTEASE INHIBITOR AND ITS COMPLEX WITH SUBTILISIN REMARK 1 TITL 3 BPN REMARK 1 REF J.MOL.BIOL. V. 75 745 1973 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 75.1 REMARK 3 NUMBER OF REFLECTIONS : 3756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 772 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.15 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.595 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.51 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.423 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SSI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-93 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : SUPPER DOUBLE FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : PROCESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4866 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 38.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 63.7 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.42667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 76.85333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 76.85333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 38.42667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.28000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: PCR REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE PRIMARY CONTACT REGION (PCR) CONSISTS OF P7 REMARK 800 -P2' RESIDUES WHICH INVOLVE THE SCISSILE BOND (OR THE REACTIVE REMARK 800 SITE PEPTIDE BOND) AND MAKE CONTACTS WITH THE TARGET ENZYMES. REMARK 800 REMARK 800 SITE_IDENTIFIER: SCR REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE SECONDARY CONTACT REGION (SCR) IS LOCATED REMARK 800 CLOSE TO THE PRIMARY CONTACT REGION. THE MAIN ROLE OF THE SCR IS REMARK 800 PERHAPS TO STABILIZE THE PRIMARY CONTACT REGION FROM INSIDE OF REMARK 800 THE INHIBITOR MOLECULE RATHER THAN TO MAKE INTERACTIONS WITH THE REMARK 800 TARGET ENZYMES. DBREF 3SSI A 1 113 UNP P01006 SSI_STRAO 32 144 SEQRES 1 A 113 ASP ALA PRO SER ALA LEU TYR ALA PRO SER ALA LEU VAL SEQRES 2 A 113 LEU THR VAL GLY LYS GLY VAL SER ALA THR THR ALA ALA SEQRES 3 A 113 PRO GLU ARG ALA VAL THR LEU THR CYS ALA PRO GLY PRO SEQRES 4 A 113 SER GLY THR HIS PRO ALA ALA GLY SER ALA CYS ALA ASP SEQRES 5 A 113 LEU ALA ALA VAL GLY GLY ASP LEU ASN ALA LEU THR ARG SEQRES 6 A 113 GLY GLU ASP VAL MET CYS PRO MET VAL TYR ASP PRO VAL SEQRES 7 A 113 LEU LEU THR VAL ASP GLY VAL TRP GLN GLY LYS ARG VAL SEQRES 8 A 113 SER TYR GLU ARG VAL PHE SER ASN GLU CYS GLU MET ASN SEQRES 9 A 113 ALA HIS GLY SER SER VAL PHE ALA PHE FORMUL 2 HOH *31(H2 O) HELIX 1 A1 ALA A 45 VAL A 56 1 12 HELIX 2 A2 ASN A 99 ASN A 104 1 6 SHEET 1 S1 4 ARG A 29 CYS A 35 0 SHEET 2 S1 4 SER A 10 GLY A 19 -1 N LEU A 12 O LEU A 33 SHEET 3 S1 4 PRO A 77 TRP A 86 -1 N LEU A 79 O GLY A 17 SHEET 4 S1 4 LYS A 89 PHE A 97 -1 N LYS A 89 O TRP A 86 SSBOND 1 CYS A 35 CYS A 50 1555 1555 2.03 SSBOND 2 CYS A 71 CYS A 101 1555 1555 2.02 CISPEP 1 ALA A 36 PRO A 37 0 -0.06 SITE 1 PCR 9 GLU A 67 ASP A 68 VAL A 69 MET A 70 SITE 2 PCR 9 CYS A 71 PRO A 72 MET A 73 VAL A 74 SITE 3 PCR 9 TYR A 75 SITE 1 SCR 5 SER A 98 ASN A 99 GLU A 100 CYS A 101 SITE 2 SCR 5 GLU A 102 CRYST1 40.740 40.740 115.280 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024546 0.014172 0.000000 0.00000 SCALE2 0.000000 0.028343 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008675 0.00000